Overview

GenScript presents a range of ready-to-use vectors tailored for mRNA researchers that enhance and surpass the conventional pUC57 and pVAX1 vectors by offering heightened cloning efficiency, poly(A) tail stability, and plasmid yield. Our offerings encompass prelinearized vectors complete with key components necessary for in vitro transcription. These vectors are available in two distinctive backbones, each coupled with four different poly(A) sequence variations and a duo of restriction enzyme digestion sites for tailored applications.

Key Benefits

More than 2-fold cloning efficiency compare to traditional pUC57 vectors

More than 2-fold cloning efficiency compare to traditional pUC57 vectors

Superior Poly(A) Stability

Superior Poly(A)
Stability

One-Stop Solution

with our Gene Synthesis, Plasmid Prep, and Cloning Services

Specification

GS-mK Vector

GS-mK Vector

Description:

The GS-MK Vector has been adapted using the pUC57-kana Vector. This involved removing the Lac promoter sequence, and placing terminator elements both before and after the MCS. These modifications have improved poly(A) tail stability and cloning efficiency.

Plasmid Type Cloning Vector
Derived from pUC57-kana
Promoter N/A
Resistance Kanamycin
Cloning Method Restriction Enzyme/MCS
Poly(A) Empty/100A/120A/30+30+43A/31+71A
Cleavage Site BspQI/BsaI

GS-CMV Vector

GS-CMV Vector

Description:

The GS-CMV Vector has been adapted using the pVAX1 Vector, a distinctive vector approved by the US FDA for clinical trials and suitable for eukaryotic transfection expression assays. GS-CMV has also incorporated terminator elements to enhance the stability of the poly(A) tail and has amplified its plasmid copy number. This ensures a decrease in potential genome contamination and minimizes the loss of quantity during plasmid extraction.

Plasmid Type Expression Vector
Derived from pVAX1
Promoter CMV
Resistance Kanamycin
Cloning Method Restriction Enzyme/MCS
Poly(A) Empty/100A/120A/30+30+43A/31+71A
Cleavage Site BspQI/BsaI

*Our mRNA vector has been deliberately crafted without a promoter. For more information please refer to the FAQ

Case Study

FAQ

1. Why does your mRNA vector lack a T7 Promoter?

A: Our mRNA vector has been deliberately crafted without a promoter and UTR regions to allow users the versatility to customize their experiments with their selected promoter and UTR sequences. To adapt the vector to your needs, just integrate your chosen promoter and UTRs alongside your ORF during the cloning process into the MCS region.

2. Can I license the mRNA applied vector for commercial use?

Certainly, we provide a commercial licensing service for clients intending to utilize our mRNA applied vectors for commercial purposes. Please contact us for further information.

3. Can I request more information on the vectors?

Certainly, we have extensive data in regards to our vector, such as Poly(A) tail stability, in vitro transcription (IVT) mRNA purity, and IVT mRNA expression levels. For more detailed information, please get in touch with us.

Resources

Relative Services

Get in Touch
with GenScript mRNA Applied Vector Service

Get in Touch  with GenScript Experts
Please enter a valid first name.
Please enter a valid last name.
Please enter a valid email name.
Please select a valid industry.
Please select a valid country.
Please enter a valid Zipcode.
Please enter a valid institution/company.
Please enter a message in the textarea.

REQUEST A QUOTE